Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 Supply Disruption — Teva Pharmaceuticals USA, Inc
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 Supply Disruption — Teva Pharmaceuticals USA, Inc is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20; Manufacturer: Teva Ph
| Drug name | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 |
|---|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc |
| Recall/Disruption reason | Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0405-2026 |
| Initiation date | 20260317 |
| Quantity affected | 19,869 Cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →